Literature DB >> 10546833

Increased expression of epidermal fatty acid binding protein, cofilin, and 14-3-3-sigma (stratifin) detected by two-dimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas.

P Sinha1, G Hütter, E Köttgen, M Dietel, D Schadendorf, H Lage.   

Abstract

In order to study possible mechanisms leading to chemoresistance in pancreatic adenocarcinoma we examined the global protein expression of pancreatic cancer cells in vitro. We used a cell culture model derived from the adenocarcinoma of the pancreas (EPP85-181P). A classical multidrug-resistant subline, EPP85-181RDB, selected in presence of daunorubicin, and an atypical multidrug-resistant cell variant, EPP85-181RNOV, selected in presence of mitoxantrone, were analyzed using two-dimensional electrophoresis. After staining and image analysis, spots of interest were isolated using preparative two-dimensional electrophoresis and subjected to mass spectrometry and microsequencing. Three proteins, E-FABP, cofilin, and 14-3-3-sigma (stratifin), were overexpressed in chemoresistant cell lines. Cofilin was present in both multidrug in chemoresistant cell lines. Cofilin was present in both multidrug-resistant cell lines. E-FABP and 14-3-3-sigma (stratifin) was found to be overexpressed only in the mitoxantrone-selected atypical multidrug-resistant cell line. The possible significance of these findings is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10546833     DOI: 10.1002/(SICI)1522-2683(19991001)20:14<2952::AID-ELPS2952>3.0.CO;2-H

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  46 in total

1.  Role of the cofilin activity cycle in astrocytoma migration and invasion.

Authors:  Shoichi Nagai; Orlando Moreno; Christian A Smith; Stacey Ivanchuk; Rocco Romagnuolo; Brian Golbourn; Adrienne Weeks; Ho Jun Seol; James T Rutka
Journal:  Genes Cancer       Date:  2011-09

Review 2.  [Proteome analysis--basis for individualized pancreatic carcinoma therapy?].

Authors:  J M Löhr; R Faissner; P Findeisen; M Neumaier
Journal:  Internist (Berl)       Date:  2006-06       Impact factor: 0.743

3.  Clinical proteomics: present and future prospects.

Authors:  Nicole M Verrills
Journal:  Clin Biochem Rev       Date:  2006-05

4.  Proteomic analysis of cell lines to identify the irinotecan resistance proteins.

Authors:  Xing-Chen Peng; Feng-Ming Gong; Meng Wei; Xi Chen; Ye Chen; Ke Cheng; Feng Gao; Feng Xu; Feng Bi; Ji-Yan Liu
Journal:  J Biosci       Date:  2010-12       Impact factor: 1.826

5.  Genetics and pathology of pancreatic cancer.

Authors:  Jordan M Winter; Anirban Maitra; Charles J Yeo
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

6.  Validation of cofilin-1 as a biomarker in non-small cell lung cancer: application of quantitative method in a retrospective cohort.

Authors:  Carolina B Müller; Rafael L S de Barros; Mauro A A Castro; Fernanda M Lopes; Rosalva T Meurer; Adriana Roehe; Guilherme Mazzini; Jane Maria Ulbrich-Kulczynski; Felipe Dal-Pizzol; Marilda C Fernandes; José C F Moreira; Léder L Xavier; Fábio Klamt
Journal:  J Cancer Res Clin Oncol       Date:  2011-07-08       Impact factor: 4.553

7.  High cofilin-1 levels correlate with cisplatin resistance in lung adenocarcinomas.

Authors:  Matheus Becker; Marco Antônio De Bastiani; Carolina Beatriz Müller; Melissa M Markoski; Mauro Antônio A Castro; Fábio Klamt
Journal:  Tumour Biol       Date:  2013-09-10

8.  14-3-3sigma, the double-edged sword of human cancers.

Authors:  Zhaomin Li; Jing-Yuan Liu; Jian-Ting Zhang
Journal:  Am J Transl Res       Date:  2009-06-08       Impact factor: 4.060

9.  14-3-3sigma Modulates pancreatic cancer cell survival and invasiveness.

Authors:  Divas Neupane; Murray Korc
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

10.  Protein kinase D1 regulates cofilin-mediated F-actin reorganization and cell motility through slingshot.

Authors:  Tim Eiseler; Heike Döppler; Irene K Yan; Kanae Kitatani; Kensaku Mizuno; Peter Storz
Journal:  Nat Cell Biol       Date:  2009-03-29       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.